Brandywine Global Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-100,899	Closed	-$5.9M	–	563
2024 Q3	$5.9M	Sell	100,899 -6,411	-6%	-$391K	0.04%	367
2024 Q2	$6.83M	Sell	107,310 -7,761	-7%	-$504K	0.05%	335
2024 Q1	$7.95M	Sell	115,071 -18,349	-14%	-$1.11M	0.06%	318
2023 Q4	$7.36M	Buy	133,420 +425	+0.3%	+$23.4K	0.06%	311
2023 Q3	$7.72M	Sell	132,995 -1,576	-1%	-$91K	0.07%	285
2023 Q2	$7.24M	Buy	134,571 +4,718	+4%	+$209K	0.06%	304
2023 Q1	$5.16M	Buy	129,853 +2,185	+2%	+$92.1K	0.04%	377
2022 Q4	$5.14M	Buy	127,668 +17,933	+16%	+$674K	0.04%	372
2022 Q3	$3.53M	Buy	109,735 +22,138	+25%	+$758K	0.03%	424
2022 Q2	$2.6M	Sell	87,597 -9,467	-10%	-$273K	0.02%	482
2022 Q1	$2.73M	Sell	97,064 -30	-0%	-$1.12K	0.02%	494
2021 Q4	$4.47M	Buy	97,094 +83,754	+628%	+$3.6M	0.03%	422
2021 Q3	$438K	Sell	13,340 -200	-1%	-$6.22K	﹤0.01%	604
2021 Q2	$475K	Sell	13,540 -1,100	-8%	-$37.4K	﹤0.01%	602
2021 Q1	$529K	Sell	14,640 -200	-1%	-$6.26K	﹤0.01%	586
2020 Q4	$431K	Buy	14,840 +164	+1%	+$4.7K	﹤0.01%	563
2020 Q3	$415K	Buy	14,676 +2,200	+18%	+$65.5K	﹤0.01%	524
2020 Q2	$404K	Buy	12,476 +200	+2%	+$7.17K	﹤0.01%	546
2020 Q1	$501K	Buy	12,276 +88	+0.7%	+$4.68K	0.01%	555
2019 Q4	$733K	Buy	12,188 +2,588	+27%	+$171K	0.01%	578
2019 Q3	$700K	Hold	9,600	–	–	0.01%	581
2019 Q2	$790K	Buy	9,600 +6,800	+243%	+$484K	0.01%	584
2019 Q1	$198K	Buy	+2,800	New	+$165K	﹤0.01%	635